4-(BROMOMETHYL)-2-OXABICYCLO[2.1.1]HEXANE, 95%, 250mg

4-Bromo-6-methoxypyridin-2-amine, 97.0%, 1g

Imidodicarbonic acid, 2-(3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-, 1,3-bis(1,1-dimethylethyl) ester, 97%, 250mg

Polyethylene Glycol Monooleyl Ether (n=approx. 20)500g

4-Ethyloctanoic acid, 95.0%, 10g

4,7-Dichloroisatin>97.0%(T)5g

acide méta-phosphorique, pa, morceaux (conditionné en verre), 100 g, emballage plastique.

3-Phenyl-2,4-pentanedione>98.0%(GC)1g

4-Amino-N-(2-hydroxyethyl)benzamide, 95.0%, 25g

4-Bromo-3-nitropyridine, 95.0%, 100mg

(6-Methyl-1,3-benzodioxol-5-yl)amine, 95.0%, 5g

Methyl 2-mercaptobenzo[d]oxazole-6-carboxylate, 95.0%, 10g

4-Chloro-5-hydroxyfuran-2(5H)-one, 95.0%, 250mg